Ending an epidemic: innovations to eradicate HIV

Governments around the world have committed to end HIV by 2030. The target is known as the 95-95-95 goals — 95 percent of people living with HIV diagnosed and knowing their status, 95 percent of those linked to HIV treatment and care and 95 percent of those on treatment to be undetectable, therefore unable to pass the virus on.

Innovative medications have already changed HIV infection from a deadly disease to a manageable chronic condition. But to end HIV entirely, we will need to invest in innovation, develop new treatment and prevention options focusing on the needs of individuals and their preferences, new healthcare policies and new approaches to fight the stigma that HIV still carries.

Host David Baker speaks to Jared Baeten, Gilead Sciences’ HIV Clinical Development Vice President; Cristina Mussini, professor of infectious diseases at the University of Modena and Reggio Emilia, Italy; Maria José Fuster, professor of psychology at Spain’s National University of Distance Education in Madrid and who has been living with HIV for 34 years; and Susana Solís Pérez, a member of the European Parliament from the Renew Europe group, to find out the practical steps that Europe needs to take to end the HIV epidemic for everyone, everywhere by the end of the decade.

Hosted on Acast. See acast.com/privacy for more information.